Seven Solutions for Neuroprotection in Parkinson's Disease-Reference-Cited by-同舟云学术

Seven Solutions for Neuroprotection in Parkinson's Disease

Published:2020-11-13 Issue:2 Volume:36 Page:306-316
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Devos David¹^ORCID,Hirsch Etienne²^ORCID,Wyse Richard³

Affiliation:

1. Department of Medical Pharmacology, Expert Center for Parkinson, CHU‐Lille, Lille Neuroscience & Cognition, Inserm, zUMR‐S1172, LICEND University of Lille Lille France

2. Institut du Cerveau—ICM, Inserm U 1127, CNRS UMR 7225 Sorbonne Université Paris France

3. The Cure Parkinson's Trust London United Kingdom

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28379

Reference92 articles.

1. Parkinson's Disease

2. The parkinson's complex: Parkinsonism is just the tip of the iceberg

3. Parkinson's Disease

4. Proteasome inhibition and Parkinson's disease modeling

5. Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease;Movement Disorders;2024-06-26

2. Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and framework;Frontiers in Systems Biology;2024-03-08

3. Advances in fluorescent probe development for bioimaging of potential Parkinson's biomarkers;European Journal of Medicinal Chemistry;2024-03

4. Pharmacotherapy for Disease Modification in Early Parkinson’s Disease: How Early Should We Be?;Journal of Parkinson's Disease;2024-02-29

5. Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease;Journal of the Neurological Sciences;2024-02